Skip to main content
Clinical Trials/IRCT2012122211841N1
IRCT2012122211841N1
Completed
未知

Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus

Vice chancellor for Administrative and Financial of Medical School0 sites46 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
lichen planus.
Sponsor
Vice chancellor for Administrative and Financial of Medical School
Enrollment
46
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for Administrative and Financial of Medical School

Eligibility Criteria

Inclusion Criteria

  • patients with disseminated lichen planus at least 6 months represent to the clinic. Exclusion criteria: 1\. Contraindications of heparin and its derivatives, including: hemostasis, acquired or congenital disorder, the risk of bleeding caused by uncontrolled hypertension, active peptic ulcer, recent cerebrovascular accident, sensitivity to enoxaparin or heparin derivatives; 2\. Chronic liver disease; 3\. Hepatitis B and C; 4\. Contraindications for taking oral prednisone; 5\. Medications that are known to lead to the LP like reaction; 6\. Lichen planus of nails; 7\. Scalp involvement; 8\. Ulcerated mucosal lesions; 9\. Heparin therapy complications such as drug sensitivity, acute bleeding.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials